ConductScience.org, home

Paper12819086

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

Coelho EA and 9 others. Infect Immun, 2003. Cited by 215 papers, by iCite.

Cite this record

ConductScience Library. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Papers, record 12819086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12819086

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
PubMed
Journal
Infect Immun
PubMed
Year
2003
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
215
iCite
Relative citation ratio, by iCite
6.36
iCite
Revised in PubMed
2021-05-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Coelho EAEduardo Antonio Ferraz
2Tavares CACarlos Alberto Pereira
3Carvalho FAFernando Aécio Amorim
4Chaves KFKarina Figueiredo
5Teixeira KNKadima Nayara
6Rodrigues RCRafaela Chitarra
7Charest HHugues
8Matlashewski GGreg
9Gazzinelli RTRicardo Tostes
10Fernandes APAna Paula

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ProtozoanMajor topic
Leishmania donovaniMajor topic
Leishmania mexicanaMajor topic
Leishmaniasis, CutaneousMajor topic
Protozoan ProteinsMajor topic
Protozoan VaccinesMajor topic
Vaccines, SyntheticMajor topic
Animals
Antibodies, Protozoan
CD4-Positive T-Lymphocytes
Female
Immunization
Immunoglobulin G
Interferon-gamma
Interleukin-10
Interleukin-4
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17545921Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.Mol Cell Biol1994https://conductscience.org/library/papers/7545921PubMed
28358705Leishmaniases of the New World: current concepts and implications for future research.Clin Microbiol Rev1993https://conductscience.org/library/papers/8358705PubMed
37642292Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.Infect Immun1995https://conductscience.org/library/papers/7642292PubMed
48813679Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.Mol Biochem Parasitol1996https://conductscience.org/library/papers/8813679PubMed
58832890Resistance to Leishmania major induced by tolerance to a single antigen.Science1996https://conductscience.org/library/papers/8832890PubMed
68864217Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.Can J Microbiol1996https://conductscience.org/library/papers/8864217PubMed
79164958Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.J Immunol1997https://conductscience.org/library/papers/9164958PubMed
89175832IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice.Immunity1997https://conductscience.org/library/papers/9175832PubMed
99314562Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.J Exp Med1997https://conductscience.org/library/papers/9314562PubMed
109394518Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.Rev Inst Med Trop Sao Paulo1997https://conductscience.org/library/papers/9394518PubMed
119662025A2rel: a constitutively expressed Leishmania gene linked to an amastigote-stage-specific gene.Mol Biochem Parasitol1998https://conductscience.org/library/papers/9662025PubMed
129686177Aging and immunoglobulin isotype patterns in oral tolerance.Braz J Med Biol Res1998https://conductscience.org/library/papers/9686177PubMed
139716105Susceptibility and resistance to Leishmania amazonensis in H-2q syngeneic high and low antibody responder mice (Biozzi mice).Scand J Immunol1998https://conductscience.org/library/papers/9716105PubMed
149834101The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.J Immunol1998https://conductscience.org/library/papers/9834101PubMed
159846579Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection.Nat Med1998https://conductscience.org/library/papers/9846579PubMed
1610092078Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.Eur J Immunol1999https://conductscience.org/library/papers/10092078PubMed
1710377151CD4(+) T cells which react to the Leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice.Infect Immun1999https://conductscience.org/library/papers/10377151PubMed
1811567746Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.Vaccine2001https://conductscience.org/library/papers/11567746PubMed
1911895981Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.Infect Immun2002https://conductscience.org/library/papers/11895981PubMed
2012151189Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen.Diagn Microbiol Infect Dis2002https://conductscience.org/library/papers/12151189PubMed

See all 38 referencesDownload CSV of references

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.

PMIDTitleJournalYearIn PapersSource
42571703Dicentrine, an Aporphine Alkaloid From Ocotea langsdorffii, Induces Mitochondrial Dysfunction and Oxidative Stress in Leishmania (L.) infantum.Chem Biodivers2026https://conductscience.org/library/papers/42571703PubMed
42296080Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary study.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/42296080PubMed
41908441Synthesis and Antileishmanial Activity of Cinnamic Acid-Amantadine Amides.ACS Omega2026https://conductscience.org/library/papers/41908441PubMed
40391226Blue light-emitting diode phototherapy presents in vitro efficacy against distinct Leishmania species and is therapeutic against tegumentary leishmaniasis in BALB/c mice.Front Immunol2025https://conductscience.org/library/papers/40391226PubMed
40160038An Update on Clinical and Pathogenic Spectra of Leishmaniasis.Expert Rev Mol Med2025https://conductscience.org/library/papers/40160038PubMed
39795229Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy.Molecules2025https://conductscience.org/library/papers/39795229PubMed
39632642An update on recombinant vaccines against leishmaniasis.Indian J Med Res2024https://conductscience.org/library/papers/39632642PubMed
39604215Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.Parasitology2025https://conductscience.org/library/papers/39604215PubMed
38543905New Approaches to the Prevention of Visceral Leishmaniasis: A Review of Recent Patents of Potential Candidates for a Chimeric Protein Vaccine.Vaccines (Basel)2024https://conductscience.org/library/papers/38543905PubMed
38035118Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches.Front Immunol2023https://conductscience.org/library/papers/38035118PubMed
37768367Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.Parasitol Res2023https://conductscience.org/library/papers/37768367PubMed
37631028Synthesis of 1,2,3-Triazole-Containing Methoxylated Cinnamides and Their Antileishmanial Activity against the Leishmania braziliensis Species.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37631028PubMed
37372136Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.Biology (Basel)2023https://conductscience.org/library/papers/37372136PubMed
36839586Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.Pathogens2023https://conductscience.org/library/papers/36839586PubMed
36839574rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis.Pathogens2023https://conductscience.org/library/papers/36839574PubMed
35891310
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection.
Vaccines (Basel)2022https://conductscience.org/library/papers/35891310PubMed
35769465Major Molecular Factors Related to Leishmania Pathogenicity.Front Immunol2022https://conductscience.org/library/papers/35769465PubMed
35145518Temporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During Leishmania amazonensis Infection in BALB/c Mice.Front Immunol2022https://conductscience.org/library/papers/35145518PubMed
35060464Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.Parasitology2021https://conductscience.org/library/papers/35060464PubMed
34952558Vaccination in Leishmaniasis: A Review Article.Iran Biomed J2022https://conductscience.org/library/papers/34952558PubMed

See all 80 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12819086

GET https://conductscience.org/api/papers/v1/12819086/references?page=2